The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Gala Renee D since year 2005.
The trader's CIK number is 1607737.
At the time of this reporting, Gala Renee D is the SVP, Chief Financial Officer of Theravance Biopharma, Inc. .
(stock ticker symbol TBPH).
See this page for all insider trading activities at Theravance Biopharma, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-08-15||TBPH||Theravance Biopharma, Inc.||Sale||41,539||27.07||1,124,336|
|2018-08-14||TBPH||Theravance Biopharma, Inc.||Sale||2,204||27.74||61,136|
|2018-05-18||TBPH||Theravance Biopharma, Inc.||Sale||10,000||24.29||242,880|
|2018-03-07||CORT||Corcept Therapeutics Inc||Buy||9,000||15.53||139,806|
|2018-03-06||CORT||Corcept Therapeutics Inc||Buy||1,000||15.30||15,300|
|2015-08-17||TBPH||Theravance Biopharma, Inc.||Buy||5,000||12.16||60,800|
|2015-08-13||TBPH||Theravance Biopharma, Inc.||Buy||5,000||12.19||60,950|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gala Renee D (SVP, Chief Financial Officer of Theravance Biopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.